Current evidence supporting the link between dietary fatty acids and cardiovascular disease

S Hammad, S Pu, PJ Jones - Lipids, 2016 - Springer
Lack of consensus exists pertaining to the scientific evidence regarding effects of various
dietary fatty acids on cardiovascular disease (CVD) risk. The objective of this article is to …

Essential fatty acids as biomedicines in cardiac health

I Balta, L Stef, I Pet, T Iancu, D Stef, N Corcionivoschi - Biomedicines, 2021 - mdpi.com
The destructive impact of cardiovascular diseases on health, including heart failure,
peripheral artery disease, atherosclerosis, stroke, and other cardiac pathological conditions …

The role of n− 6 and n− 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease

J Monteiro, M Leslie, MH Moghadasian, BM Arendt… - Food & function, 2014 - pubs.rsc.org
Cardiovascular disease (CVD) and non-alcoholic fatty liver disease (NAFLD) are
manifestations of the metabolic syndrome. CVD remains the number one cause of mortality …

Long chain omega-3 fatty acids and cardiovascular disease: a systematic review

J Delgado-Lista, P Perez-Martinez… - British Journal of …, 2012 - cambridge.org
Introduction: Cardiovascular disease remains the commonest health problem in developed
countries, and residual risk after implementing all current therapies is still high. The use of …

Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action

H Poudyal, SK Panchal, V Diwan, L Brown - Progress in lipid research, 2011 - Elsevier
Epidemiological, human, animal, and cell culture studies show that n− 3 fatty acids,
especially α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid …

Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids

Y Adkins, DS Kelley - The Journal of nutritional biochemistry, 2010 - Elsevier
Typical omega 3 polyunsaturated fatty acids (n-3 PUFAs) are docosahexaenoic acid and
eicosapentaenoic acid in the form of fish oils and α linolenic acid from flaxseed oil …

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis

EC Rizos, EE Ntzani, E Bika, MS Kostapanos… - Jama, 2012 - jamanetwork.com
Context Considerable controversy exists regarding the association of omega-3
polyunsaturated fatty acids (PUFAs) and major cardiovascular end points. Objective To …

Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effects vs. clinical outcomes

RN Thota, JJA Ferguson, KA Abbott, CB Dias… - Food & function, 2018 - pubs.rsc.org
Lower incidence of cardiovascular disease (CVD) in the Greenland Inuit, Northern Canada
and Japan has been attributed to their consumption of seafood rich in long chain omega-3 …

n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations

S Czernichow, D Thomas, E Bruckert - British Journal of Nutrition, 2010 - cambridge.org
n-6 PUFA are well known for their critical role in many physiological functions and seem to
reduce risks of CHD. However, some argue that excessive consumption of n-6 PUFA may …

The effects of linoleic acid consumption on lipid risk markers for cardiovascular disease in healthy individuals: A review of human intervention trials

E Froyen, B Burns-Whitmore - Nutrients, 2020 - mdpi.com
Cardiovascular disease (CVD) is the leading cause of death worldwide. Risk factors for
developing this disease include high serum concentrations of total cholesterol, triglycerides …